News Bayer left playing catch-up with BMS after Xarelto failure BMS' rival anticoagulant takes commanding market lead.
News NICE recommends Bayer drug for severe short-sightedness Eylea should be funded in mCNV, says NICE
News Bayer gains first Aliqopa approval in follicular lymphoma Bayer has gained FDA accelerated approval for its follicular lymphoma drug Aliqopa (copanlisib), giving it entry to the haemato-oncology market for the first time.
News Bayer unveils latest funding for digital health start-ups Startups focus on medical adherence, endometriosis, atrial fibrillation, and deep vein thrombosis.
News EUSA Pharma's Fotivda approved in EU for kidney cancer UK pharma gets licence for second cancer drug
News NICE close to clearing Cancer Drugs Fund backlog Only five drugs left to assess from old scheme.
News NICE changes stance on Genmab's cervical cancer drug After saying it couldn't recommend Genmab's cervical cancer therapy Tivdak for use by the NHS, reimbursement authority NICE has had a change of heart.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
